235 related articles for article (PubMed ID: 24379101)
21. Thermo-sensitive mitochondrial trifunctional protein deficiency presenting with episodic myopathy.
Schwantje M; Ebberink MS; Doolaard M; Ruiter JPN; Fuchs SA; Darin N; Hedberg-Oldfors C; Régal L; Donker Kaat L; Huidekoper HH; Olpin S; Cole D; Moat SJ; Visser G; Ferdinandusse S
J Inherit Metab Dis; 2022 Jul; 45(4):819-831. PubMed ID: 35403730
[TBL] [Abstract][Full Text] [Related]
22. Energy exchangers with LCT as a precision method for diet control in LCHADD.
Mozrzymas R; Konikowska K; Regulska-Ilow B
Adv Clin Exp Med; 2017; 26(3):515-525. PubMed ID: 28791828
[TBL] [Abstract][Full Text] [Related]
23. Analysis of a family with mitochondrial trifunctional protein deficiency caused by
Yang J; Yuan D; Tan X; Zeng Y; Tang N; Chen D; Tan J; Cai R; Huang J; Yan T
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34878152
[TBL] [Abstract][Full Text] [Related]
24. Genetic, biochemical, and clinical spectrum of patients with mitochondrial trifunctional protein deficiency identified after the introduction of newborn screening in the Netherlands.
Schwantje M; Fuchs SA; de Boer L; Bosch AM; Cuppen I; Dekkers E; Derks TGJ; Ferdinandusse S; Ijlst L; Houtkooper RH; Maase R; van der Pol WL; de Vries MC; Verschoof-Puite RK; Wanders RJA; Williams M; Wijburg F; Visser G
J Inherit Metab Dis; 2022 Jul; 45(4):804-818. PubMed ID: 35383965
[TBL] [Abstract][Full Text] [Related]
25. Deregulation of mitochondrial functions provoked by long-chain fatty acid accumulating in long-chain 3-hydroxyacyl-CoA dehydrogenase and mitochondrial permeability transition deficiencies in rat heart--mitochondrial permeability transition pore opening as a potential contributing pathomechanism of cardiac alterations in these disorders.
Cecatto C; Hickmann FH; Rodrigues MD; Amaral AU; Wajner M
FEBS J; 2015 Dec; 282(24):4714-26. PubMed ID: 26408230
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of earlier versus later dietary management in long-chain 3-hydroxyacyl-CoA dehydrogenase or mitochondrial trifunctional protein deficiency: a systematic review.
Fraser H; Geppert J; Johnson R; Johnson S; Connock M; Clarke A; Taylor-Phillips S; Stinton C
Orphanet J Rare Dis; 2019 Nov; 14(1):258. PubMed ID: 31730477
[TBL] [Abstract][Full Text] [Related]
27. Increased and early lipolysis in children with long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency during fast.
Haglind CB; Nordenström A; Ask S; von Döbeln U; Gustafsson J; Stenlid MH
J Inherit Metab Dis; 2015 Mar; 38(2):315-22. PubMed ID: 25141826
[TBL] [Abstract][Full Text] [Related]
28. Sensory neuronopathy as a major clinical feature of mitochondrial trifunctional protein deficiency in adults.
Nadjar Y; Souvannanorath S; Maisonobe T; Brisset M; De Lonlay P; Schiff M; Viala K; Boutron A; Nicolas G; Laforêt P
Rev Neurol (Paris); 2020 May; 176(5):380-386. PubMed ID: 32253025
[TBL] [Abstract][Full Text] [Related]
29. Triheptanoin versus trioctanoin for long-chain fatty acid oxidation disorders: a double blinded, randomized controlled trial.
Gillingham MB; Heitner SB; Martin J; Rose S; Goldstein A; El-Gharbawy AH; Deward S; Lasarev MR; Pollaro J; DeLany JP; Burchill LJ; Goodpaster B; Shoemaker J; Matern D; Harding CO; Vockley J
J Inherit Metab Dis; 2017 Nov; 40(6):831-843. PubMed ID: 28871440
[TBL] [Abstract][Full Text] [Related]
30. Disturbance of mitochondrial functions provoked by the major long-chain 3-hydroxylated fatty acids accumulating in MTP and LCHAD deficiencies in skeletal muscle.
Cecatto C; Godoy KDS; da Silva JC; Amaral AU; Wajner M
Toxicol In Vitro; 2016 Oct; 36():1-9. PubMed ID: 27371118
[TBL] [Abstract][Full Text] [Related]
31. Earlier diagnosis and strict diets improve the survival rate and clinical course of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.
Immonen T; Turanlahti M; Paganus A; Keskinen P; Tyni T; Lapatto R
Acta Paediatr; 2016 May; 105(5):549-54. PubMed ID: 26676313
[TBL] [Abstract][Full Text] [Related]
32. Retinal Dystrophy in Long-Chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency.
Androudi S; Mataftsi A; Brazitikos P
Ophthalmol Retina; 2018 Jan; 2(1):74. PubMed ID: 31047310
[No Abstract] [Full Text] [Related]
33. Hypoparathyroidism, neutropenia and nephrotic syndrome in a patient with mitochondrial trifunctional protein deficiency: A case report and review of the literature.
Li Y; He C; Li S; Wang J; Jiang L; Guo Y
Eur J Med Genet; 2021 Dec; 64(12):104344. PubMed ID: 34543737
[TBL] [Abstract][Full Text] [Related]
34. Impact of newborn screening for fatty acid oxidation disorders on neurological outcome: A Belgian retrospective and multicentric study.
Everard E; Laeremans H; Boemer F; Marie S; Vincent MF; Dewulf JP; Debray FG; De Laet C; Nassogne MC
Eur J Paediatr Neurol; 2024 Mar; 49():60-65. PubMed ID: 38377647
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological inhibition of carnitine palmitoyltransferase 1 restores mitochondrial oxidative phosphorylation in human trifunctional protein deficient fibroblasts.
Lefort B; Gouache E; Acquaviva C; Tardieu M; Benoist JF; Dumas JF; Servais S; Chevalier S; Vianey-Saban C; Labarthe F
Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1292-1299. PubMed ID: 28392417
[TBL] [Abstract][Full Text] [Related]
36. Trifunctional Protein Deficiency Due to HADHB Mutations Is a Multisystem, β-Oxidation Disorder.
Finsterer J; Zarrouk-Mahjoub S
Arch Iran Med; 2017 Dec; 20(12):767-769. PubMed ID: 29664318
[No Abstract] [Full Text] [Related]
37. The spectrum of peripheral neuropathy in disorders of the mitochondrial trifunctional protein.
Grünert SC; Eckenweiler M; Haas D; Lindner M; Tsiakas K; Santer R; Tucci S; Spiekerkoetter U
J Inherit Metab Dis; 2021 Jul; 44(4):893-902. PubMed ID: 33638202
[TBL] [Abstract][Full Text] [Related]
38. Mitochondrial trifunctional protein deficiency in human cultured fibroblasts: effects of bezafibrate.
Djouadi F; Habarou F; Le Bachelier C; Ferdinandusse S; Schlemmer D; Benoist JF; Boutron A; Andresen BS; Visser G; de Lonlay P; Olpin S; Fukao T; Yamaguchi S; Strauss AW; Wanders RJ; Bastin J
J Inherit Metab Dis; 2016 Jan; 39(1):47-58. PubMed ID: 26109258
[TBL] [Abstract][Full Text] [Related]
39. Muscle MRI in patients with long-chain fatty acid oxidation disorders.
Diekman EF; van der Pol WL; Nievelstein RA; Houten SM; Wijburg FA; Visser G
J Inherit Metab Dis; 2014 May; 37(3):405-13. PubMed ID: 24305961
[TBL] [Abstract][Full Text] [Related]
40. Severe combined immunodeficiency resulting from mutations in MTHFD1.
Keller MD; Ganesh J; Heltzer M; Paessler M; Bergqvist AG; Baluarte HJ; Watkins D; Rosenblatt DS; Orange JS
Pediatrics; 2013 Feb; 131(2):e629-34. PubMed ID: 23296427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
